Due to the hyperpermeability of the vasculature in tumor tissues, the incorporation of TRAIL in nanoparticles can facilitate its preferential accumulation in tumor sites, a process called passive targeting [188] (Table 1). Here, TNFSF10 is linked to neoplasm.